Notification of regenerative medicine provision plan
Our hospital has acquired a Type 3 regenerative medicine provision plan number.
Regenerative medicine can only be provided by licensed doctors at facilities whose notification to the Ministry of Health, Labour and Welfare has been accepted.
Our hospital is a medical facility that has submitted a Type 3 regenerative medicine provision plan and obtained a plan number in accordance with the Regenerative Medicine Act (Act on Ensuring the Safety of Regenerative Medicine, etc.).
Our hospital has been approved for the "Type 3 Regenerative Medicine Provision Plan"
● WT1 dendritic cell vaccine therapy
●Activated lymphocyte therapy for malignant tumors
●NKT cell-targeted therapy using dendritic cells (αNKT therapy) for malignant tumors
●Natural killer (NK) cell therapy for malignant tumors
●Natural killer (NK) cell therapy (prevention of malignant tumors)
● Immune function improvement therapy using αβT cells against cancer
● Dendritic cell vaccine therapy for malignant tumors
● Immune function improvement therapy using NKT cell-activated dendritic cells against cancer
● Skin regeneration treatment using platelet-rich plasma (PRP)
● Hair improvement treatment using platelet-rich plasma
